top of page

A New Ultrasound Treatment Platform – SonoFusion

Learn More

The Problem

Line

Approximately 30%–40% of the global population is likely to experience at least one of the following medical conditions during their lifetime:

â–¶ Cancer: Liver, breast, prostate, kidney, and pancreatic cancers.

â–¶ Bone Metastases: Pain and complications associated with advanced cancer.

â–¶ Heart Issues: Arrhythmias requiring cardiac tissue ablation.

â–¶ Urological Problems: Benign prostatic hyperplasia (BPH) and prostate cancer.

â–¶ Gynecological Disorders: Endometriosis and adenomyosis.

â–¶ Neurological Diseases: Parkinson’s disease and essential tremor.

â–¶ Women’s Health: Uterine fibroids.

Approximately 50%–60% of patients with these conditions may not be suitable for surgery:

â–¶ Inoperable Conditions

â–¶ Hard-to-Reach Areas

â–¶ Post-Treatment Recovery

â–¶ High surgery operation cost

Platform
Platform

Platform

Line

Our mission

Our mission is to revolutionize healthcare by replacing invasive surgeries with effective, non-invasive solution. We aim to deliver treatments that are accessible to more patients, enable faster recovery, and are affordable for everyone. By providing a low-cost system for every physician's clinic, we strive to make advanced care universally available.

Our solution

Our solution is an innovative ultrasound treatment platform that combines histotripsy and thermal ablation to deliver precise, non-invasive ultrasound procedure.

Histotripsy

  • High-amplitude, short-pulsing (microsecond) sound energy is directed at the targeted tissue

  • Rapid expansion and collapse of micro-bubbles destroy targeted tissue at a sub-cellular level

  • Capable of sub-millimeter precision

Thermal

  • High-amplitude, sub second sound energy is directed at the targeted tissue

  • Fast temperature rise destroys targeted tissue

  • No bleeding and other side effects

play

Advantages

  • Ultra-Fast treatment.

  • Simple patient interface.

  • Non-invasive: Safe, No surgery, reducing risks, fast recovery time.

  • No MRI required: Affordable and accessible for small clinics.

  • Cost-effective: Simple, low-cost design.

Ultrasound Feedback

Line

Electronically steered ablation

Thermal ablation
Ultrasound feedback

Precise focal ablation

Thermal ablation
Ultrasound feedback

The Team

Line
20211118_120308_edited.avif
CEO.png

Evgeny Belov, B.Sce
 

  • 16 years of medical device industry experience and commercial leadership.

  • Sofwave, Syneron-Candela, Iluminage, Neuronix, Chronisense, Arineta, Horizon 2020

Oleg Prus_edited.avif
CTO.png

Oleg Prus, PhD.

​

  • 20 years of experience in high-power focused ultrasound (HIFU) transducer technology, ultrasound technology development, algorithmics, simulations.

  • Insightec

Team
Investors
contact.jpg

Contact Us

Fill in the form below as accurately as possible & we will contact you soon!

​Email 

contact@sono-fusion.com

Call

+972-48339231

Linkedin

Follow Us

Location 

Tuukri 19-315, Tallinn, Estonia

We will contact you soon!

bottom of page